Condition*† | ASID (Australasia)9 | CDC (USA)8 | CCIRH (Canada)10 |
---|---|---|---|
Tuberculosis | All | All |
|
Malaria | All | Sub-Saharan African refugees with no predeparture therapy receive presumptive treatment/screening | Not routine |
Schistosomiasis | African and South-East Asian refugees | Presumptive treatment/screening if no predeparture therapy or symptomatic | African refugees |
Strongyloides | All | African and South-East Asian refugees | |
Other intestinal helminths | Presumptive treatment/screening if no predeparture therapy/symptomatic/eosinophilia | Not specified | |
HBV | All | ≥18 years from countries with moderate/high rate of chronic HBV (≥2%) and no documentation of negative HBsAg or risk factors present | Refugees from countries with moderate/high rate of chronic HBV (≥2% positive HBsAg) |
Hepatitis C | All | Anyone with risk factors | Refugees from countries with a prevalence of ≥3% |
HIV | All |
| Adolescents and adults from countries with a prevalence of >1% |
Syphilis | All |
| Not routine |
Chlamydia trachomatis |
| Refugees with symptoms or risk factors | Not routine |
Neisseria gonorrhoeae | |||
Immunisations | Catch-up regimen according to Australian Standard Immunisation Schedule | Catch-up regimen according to the Advisory Committee on Immunization Practices | Refugees at risk‡ |
*Specific investigations/diagnostic algorithms are outlined in the referenced guidelines and will be host-country dependent.
†Informed consent for screening must be undertaken at the time, with use of professional interpreters as required.
‡Vaccination updates for measles, mumps, rubella, polio, diphtheria, tetanus, pertussis, hepatitis B, varicella and human papillomavirus.
ASID, Australasian Society for Infectious Diseases; CDC, Centers for Disease Control and Prevention; CCIRH, Canadian Collaboration for Immigrant and Refugee Health; HBV, Hepatitis B virus; HBsAg, Hepatitis B surface antigen.